Market Resilience: Amneal Pharmaceuticals Inc (AMRX) Finishes Strong at 8.44, Up 1.32

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Amneal Pharmaceuticals Inc (NASDAQ: AMRX) closed the day trading at $8.44 up 1.32% from the previous closing price of $8.33. In other words, the price has increased by $1.32 from its previous closing price. On the day, 0.71 million shares were traded. AMRX stock price reached its highest trading level at $8.4599 during the session, while it also had its lowest trading level at $8.11.

Ratios:

For a better understanding of AMRX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 33.38 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.82. For the most recent quarter (mrq), Quick Ratio is recorded 0.84 and its Current Ratio is at 1.38.

Goldman Upgraded its Sell to Buy on March 08, 2021, whereas the target price for the stock was revised from $4 to $6.50.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 15 ’24 when Daly Jason B. sold 43,657 shares for $8.61 per share. The transaction valued at 375,887 led to the insider holds 13,665 shares of the business.

Daly Jason B. bought 57,322 shares of AMRX for $487,237 on Nov 15 ’24. On Aug 15 ’24, another insider, BOYER ANDREW S, who serves as the Executive Vice President of the company, sold 40,225 shares for $7.85 each. As a result, the insider received 315,766 and left with 256,670 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMRX now has a Market Capitalization of 3898950656 and an Enterprise Value of 5242243072. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.98. Its current Enterprise Value per Revenue stands at 1.956 whereas that against EBITDA is 9.249.

Stock Price History:

Over the past 52 weeks, AMRX has reached a high of $9.48, while it has fallen to a 52-week low of $4.16. The 50-Day Moving Average of the stock is -1.59%, while the 200-Day Moving Average is calculated to be 18.85%.

Shares Statistics:

Over the past 3-months, AMRX traded about 1.16M shares per day on average, while over the past 10 days, AMRX traded about 1578950 shares per day. A total of 306.56M shares are outstanding, with a floating share count of 122.91M. Insiders hold about 60.33% of the company’s shares, while institutions hold 41.69% stake in the company. Shares short for AMRX as of 1730332800 were 3501178 with a Short Ratio of 3.03, compared to 1727654400 on 4529494. Therefore, it implies a Short% of Shares Outstanding of 3501178 and a Short% of Float of 1.3599999999999999.

Most Popular